Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Multi-phase, Multi-dose, Prospective, Double-blind, Placebo-controlled, Maintenance Study of Safety and Efficacy of ZS (Microporous, Fractionated, Protonated Zirconium Silicate) in Hyperkalemia.

NCT02088073 is registered in ClinicalTrials.gov with ZS Pharma, Inc. as lead sponsor.

NCT NCT02088073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02088073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Multi-phase, Multi-dose, Prospective, Double-blind, Placebo-controlled, Maintenance Study of Safety and Efficacy of ZS (Microporous, Fractionated, Protonated Zirconium Silicate) in Hyperkalemia.
Lead sponsor
ZS Pharma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2014
Completion date
January 31, 2015
Enrollment
258 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia